Article
Proof-of-concept for multiple AON delivery by a single U7snRNA vector to restore splicing defects in ABCA4.
Molecular therapy : the journal of the American Society of Gene Therapy - 6 Mar 2024
Suárez-Herrera Nuria, Riswick Iris B, Vázquez-Domínguez Irene, Duijkers Lonneke, Karjosukarso Dyah W, Piccolo Davide, Bauwens Miriam, De Baere Elfride, Cheetham Michael E, Garanto Alejandro, Collin Rob W J
Abstract excerpt
The high allelic heterogeneity in Stargardt disease (STGD1) complicates the design of intervention strategies. A significant proportion of pathogenic intronic ABCA4 variants alters the pre-mRNA splicing process. Antisense oligonucleotides (AONs) are an attractive yet mutation-specific therapeutic strategy to restore these splicing defects. In this study, we experimentally assessed the potential of a splicing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
